Lombard Odier Asset Management (Switzerland)’s West Pharmaceutical WST Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$231K	Buy	+920	New	+$229K	0.01%	448
2022 Q1	–	Sell	-503	Closed	-$236K	–	397
2021 Q4	$236K	Buy	+503	New	+$217K	0.02%	349
2021 Q3	–	Sell	-926	Closed	-$333K	–	482
2021 Q2	$333K	Buy	+926	New	+$306K	0.02%	409
2020 Q4	–	Sell	-2,959	Closed	-$813K	–	358
2020 Q3	$813K	Buy	+2,959	New	+$783K	0.09%	171
2020 Q2	–	Sell	-1,824	Closed	-$278K	–	334
2020 Q1	$278K	Buy	+1,824	New	+$281K	0.04%	286
2019 Q2	–	Sell	-68,000	Closed	-$7.49M	–	396
2019 Q1	$7.49M	Buy	+68,000	New	+$7.07M	0.76%	40
2018 Q2	–	Sell	-50,000	Closed	-$4.42M	–	380
2018 Q1	$4.42M	Hold	50,000	–	–	0.46%	45
2017 Q4	$4.93M	Sell	50,000 -30,000	-38%	-$2.94M	0.48%	51
2017 Q3	$7.7M	Buy	+80,000	New	+$7.24M	0.75%	34
2015 Q1	–	Sell	-75,275	Closed	-$4.03M	–	478
2014 Q4	$4.03M	Buy	75,275 +3,399	+5%	+$170K	0.43%	42
2014 Q3	$3.23M	Buy	+71,876	New	+$3.05M	0.08%	259

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s WST Position: Q1 2026 in Review

Lombard Odier Asset Management (Switzerland) opened a new position in West Pharmaceutical (WST) in Q1 2026: 920 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #448 among its holdings. This is a return to the name: Lombard Odier Asset Management (Switzerland) previously reported a position in WST as recently as Q4 2021.

Lombard Odier Asset Management (Switzerland) first reported a position in WST in Q3 2014 and has held it in 11 quarters since. The position peaked at $7.7M in Q3 2017. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Lombard Odier Asset Management (Switzerland) held 920 shares of West Pharmaceutical worth $231K as of Q1 2026.
West Pharmaceutical was a new Lombard Odier Asset Management (Switzerland) position in Q1 2026.
West Pharmaceutical made up 0.01% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #448 holding.
Lombard Odier Asset Management (Switzerland) first reported a position in West Pharmaceutical in Q3 2014 and has held it in 11 quarters since.
Lombard Odier Asset Management (Switzerland)'s West Pharmaceutical position peaked at $7.7M in Q3 2017.
754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.